Oxygen Biotherapeutics, Inc. (OXBO) Announces 20:1 Reverse Stock Split Effective After Market Close on May 10th
5/10/2013 11:26:16 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), today announced the effectiveness of a 20-to-one reverse stock split of its common stock. The reverse stock split was approved by the Company’s stockholders at a Special Meeting of Stockholders held on April 26, 2013, and was approved by the Company’s Board of Directors on that same date.
Help employers find you! Check out all the jobs and post your resume.
comments powered by